Earnings History Data for Ikena Oncology (IKNA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Ikena Oncology
Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | IKNA | Ikena Oncology | 82.00 | -0.19 | -0.27 | 0.00 | Ikena Oncology GAAP EPS of -$0.21 beats by $0.06 [11/7/2024 11:21 AM] |
1.70 | -0.02 (-1.16%) |
0.0 | 0.0 (0.00%) |
1.02 - 4.34 | 28,390 | 40,000 | 0 | ||
| 08-08-2024 | PM | IKNA | Ikena Oncology, Inc. | 79.63 | -0.27 | -0.31 | -0.44 | Ikena Oncology GAAP EPS of -$0.28 [8/9/2024 7:23 AM] |
1.63 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
1.02 - 5.20 | 113,393 | 90,000 | 0 | ||
| 13-05-2024 | AH | IKNA | Ikena Oncology | 65.00 | -0.28 | -0.40 | 0.00 | Ikena Oncology reports Q1 GAAP EPS of -$0.33 [5/14/2024 10:59 AM] |
1.31 | -0.01 (-0.38%) |
1.34 | 0.02 (1.37%) |
1.02 - 7.38 | 200,176 | 220,000 | 1,501 | ||
| 09-11-2023 | PM | IKNA | Ikena Oncology | 174.00 | -0.40 | -0.44 | 0.00 | 1.33 | -2.80 (-67.80%) |
3.82 | -0.31 (-7.51%) |
1.02 - 7.64 | 3,350,279 | 60,000 | 3,192 | |||
| 15-05-2023 | PM | 8:05 AM ET (May 15) |
IKNA | Ikena Oncology | 263.00 | -0.39 | -0.46 | 0.00 | Ikena Oncology GAAP EPS of -$0.39 beats by $0.08, revenue of $5.3M beats by $0.68M [5/15/2023 12:26 PM] |
6.96 | -0.04 (-0.50%) |
6.70 | -0.30 (-4.29%) |
1.94 - 7.64 | 62,063 | 100,000 | 5,797 | |
| 14-03-2023 | PM | IKNA | Ikena Oncology | 164.00 | -0.39 | -0.53 | 0.00 | Ikena Oncology GAAP EPS of -$0.39 misses by $0.25, revenue of $5.45M misses by $14.51M [3/14/2023 7:51 AM] |
4.30 | 0.08 (1.90%) |
0.0 | 0.0 (0.00%) |
1.94 - 8.99 | 24,429 | 60,000 | 0 | ||
| 07-11-2022 | PM | IKNA | Ikena Oncology | 94.00 | -0.48 | -0.50 | 0.00 | Ikena Oncology GAAP EPS of -$0.48 beats by $0.01, revenue of $6.4M beats by $2.08M [11/7/2022 8:28 AM] |
2.29 | 0.02 (0.88%) |
2.32 | 0.05 (2.20%) |
2.25 - 17.50 | 123,395 | 70,000 | 551 | ||
| 17-03-2022 | PM | IKNA | Ikena Oncology, Inc. | 201.44 | 0.07 | -0.52 | 0.00 | Ikena Oncology GAAP EPS of $0.08 beats by $0.59, revenue of $20.21M beats by $15.42M [3/17/2022 9:14 AM] |
7.77 | 1.46 (23.14%) |
6.36 | 0.05 (0.79%) |
5.31 - 37.61 | 101,316 | 133,270 | 4,265 | ||
| 10-11-2021 | PM | IKNA | Ikena Oncology | 541.00 | -0.40 | -0.41 | 0.00 | Ikena Oncology EPS beats by $0.02, misses on revenue [11/10/2021 9:08 AM] |
16.57 | 1.49 (9.88%) |
0.0 | 0.0 (0.00%) |
9.63 - 37.61 | 114,768 | 120,000 | 0 | ||